MedPath

A comparative clinical trial to assess the effectiveness of two doses of bupivacaine in PENG block for relieving pain during hip fracture surgery

Not Applicable
Completed
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2022/03/040748
Lead Sponsor
Dr RP Govt Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
60
Inclusion Criteria

The study shall be conducted on 60 consecutive patients belonging to 40â??90 years of age range, American Society of Anaesthesiology Grade I/III and with a body mass index (BMI) of 18.5â??29.9 kg/m2.

Exclusion Criteria

Patient refusal for spinal anaesthesia, infection at the puncture site, coagulopathies, neuropathies, and any other contraindication to neuraxial block will be excluded from this study. Parturient patients and those with BMI of >30 kg/m2 will also be excluded from the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To measure the ease of sitting for the conduct of regional anaesthesia (graded as: 0-not satisfactory, 1-satisfactory, 2-good and 3-optimal) <br/ ><br>Timepoint: After 20 minutes (T 20) of application/institution of PENG block <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
The pain assessment after the block utilizing VAS score.Timepoint: At 10 min and 20 min.
© Copyright 2025. All Rights Reserved by MedPath